The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia

Published:2016-11 Issue: Volume:50 Page:1-10
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Leclerc Gilles M.,Zheng Shuhua,Leclerc Guy J.,DeSalvo Joanna,Swords Ronan T.,Barredo Julio C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference46 articles.

1. Cancer statistics, 2012;Siegel;CA. Cancer J. Clin.,2012

2. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there;Pui;Blood,2012

3. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia;DeSalvo;Mol. Cancer Res.,2012

4. Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts;Leclerc;PLoS One,2013

5. Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia;Kharabi Masouleh;Proc. Natl. Acad. Sci. U. S. A.,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct Pathway Activities are Associated with Prognosis and Response to Bortezomib- containing Treatment in MCL1-M Based Molecular Subtypes of Multiple Myeloma;2024-03-05

2. Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712;Pediatric Blood & Cancer;2023-09-14

3. AMPK Associates with Chromatin and Phosphorylates the TAF-1 Subunit of the Transcription Initiation Complex to Regulate Histone Gene Expression in ALL Cells;Molecular Cancer Research;2023-09-08

4. New Therapeutic Strategies for Adult Acute Myeloid Leukemia;Cancers;2022-06-05

5. Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms;Frontiers in Immunology;2021-06-01